CVS Health Price to Sales Ratio 2010-2025 | CVS
Historical PS ratio values for CVS Health (CVS) over the last 10 years. The current P/S ratio for CVS Health as of July 18, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| CVS Health P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-07-18 | 61.96 | 0.21 | |
| 2025-03-31 | 67.06 | $300.52 | 0.22 |
| 2024-12-31 | 43.87 | $295.49 | 0.15 |
| 2024-09-30 | 60.78 | $290.79 | 0.21 |
| 2024-06-30 | 56.45 | $284.57 | 0.20 |
| 2024-03-31 | 75.51 | $281.20 | 0.27 |
| 2023-12-31 | 74.07 | $277.46 | 0.27 |
| 2023-09-30 | 64.94 | $268.11 | 0.24 |
| 2023-06-30 | 63.78 | $260.24 | 0.25 |
| 2023-03-31 | 68.00 | $252.19 | 0.27 |
| 2022-12-31 | 84.69 | $243.99 | 0.35 |
| 2022-09-30 | 86.15 | $238.25 | 0.36 |
| 2022-06-30 | 83.22 | $232.06 | 0.36 |
| 2022-03-31 | 90.43 | $225.74 | 0.40 |
| 2021-12-31 | 91.68 | $220.16 | 0.42 |
| 2021-09-30 | 74.98 | $215.45 | 0.35 |
| 2021-06-30 | 73.28 | $210.92 | 0.35 |
| 2021-03-31 | 65.64 | $205.92 | 0.32 |
| 2020-12-31 | 59.20 | $204.53 | 0.29 |
| 2020-09-30 | 50.19 | $202.86 | 0.25 |
| 2020-06-30 | 55.41 | $201.53 | 0.27 |
| 2020-03-31 | 50.18 | $200.52 | 0.25 |
| 2019-12-31 | 62.41 | $196.98 | 0.32 |
| 2019-09-30 | 52.58 | $197.86 | 0.27 |
| 2019-06-30 | 45.03 | $194.66 | 0.23 |
| 2019-03-31 | 44.14 | $192.04 | 0.23 |
| 2018-12-31 | 53.22 | $189.58 | 0.28 |
| 2018-09-30 | 63.50 | $184.72 | 0.34 |
| 2018-06-30 | 51.52 | $183.53 | 0.28 |
| 2018-03-31 | 49.43 | $182.05 | 0.27 |
| 2017-12-31 | 57.25 | $180.17 | 0.32 |
| 2017-09-30 | 63.79 | $175.52 | 0.36 |
| 2017-06-30 | 62.71 | $171.83 | 0.36 |
| 2017-03-31 | 60.79 | $167.89 | 0.36 |
| 2016-12-31 | 60.74 | $164.20 | 0.37 |
| 2016-09-30 | 68.16 | $158.12 | 0.43 |
| 2016-06-30 | 73.01 | $151.01 | 0.48 |
| 2016-03-31 | 78.78 | $143.17 | 0.55 |
| 2015-12-31 | 73.92 | $135.83 | 0.54 |
| 2015-09-30 | 72.70 | $130.99 | 0.56 |
| 2015-06-30 | 78.78 | $126.60 | 0.62 |
| 2015-03-31 | 77.26 | $123.24 | 0.63 |
| 2014-12-31 | 71.84 | $118.73 | 0.61 |
| 2014-09-30 | 59.17 | $113.81 | 0.52 |
| 2014-06-30 | 55.83 | $109.77 | 0.51 |
| 2014-03-31 | 55.25 | $105.58 | 0.52 |
| 2013-12-31 | 52.60 | $102.88 | 0.51 |
| 2013-09-30 | 41.55 | $100.62 | 0.41 |
| 2013-06-30 | 41.71 | $98.30 | 0.42 |
| 2013-03-31 | 39.96 | $96.89 | 0.41 |
| 2012-12-31 | 34.98 | $95.64 | 0.37 |
| 2012-09-30 | 34.91 | $92.13 | 0.38 |
| 2012-06-30 | 33.58 | $88.31 | 0.38 |
| 2012-03-31 | 32.07 | $83.81 | 0.38 |
| 2011-12-31 | 29.08 | $79.02 | 0.37 |
| 2011-09-30 | 23.87 | $75.66 | 0.32 |
| 2011-06-30 | 26.62 | $73.09 | 0.36 |
| 2011-03-31 | 24.22 | $71.26 | 0.34 |
| 2010-12-31 | 24.45 | $69.54 | 0.35 |
| 2010-09-30 | 22.07 | $69.34 | 0.32 |
| 2010-06-30 | 20.50 | $69.06 | 0.30 |
| 2010-03-31 | 25.50 | $68.42 | 0.37 |
| 2009-12-31 | 22.41 | $67.33 | 0.33 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $78.381B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $136.013B | 25.51 |
| Elevance Health (ELV) | United States | $62.604B | 8.39 |
| Cencora (COR) | United States | $56.765B | 19.75 |
| DiDi Global (DIDIY) | China | $26.874B | 28.55 |
| Labcorp Holdings (LH) | United States | $20.399B | 16.55 |
| Natera (NTRA) | United States | $18.966B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.991B | 0.00 |
| CochLear (CHEOY) | Australia | $13.143B | 0.00 |
| Solventum (SOLV) | United States | $12.678B | 13.42 |
| ICON (ICLR) | Ireland | $11.592B | 10.78 |
| Revvity (RVTY) | United States | $10.993B | 18.92 |
| Viatris (VTRS) | United States | $10.422B | 3.58 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| Medpace Holdings (MEDP) | United States | $8.964B | 23.81 |
| Sonic Healthcare (SKHHY) | Australia | $8.852B | 0.00 |
| HealthEquity (HQY) | United States | $8.449B | 37.01 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.680B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.587B | 14.87 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.918B | 28.96 |
| BrightSpring Health Services (BTSG) | United States | $3.506B | 32.17 |
| Sotera Health (SHC) | United States | $3.139B | 17.84 |
| Surgery Partners (SGRY) | United States | $2.861B | 37.20 |
| Concentras Parent (CON) | United States | $2.507B | 14.49 |
| Organon (OGN) | United States | $2.459B | 2.61 |
| Alignment Healthcare (ALHC) | United States | $2.455B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.222B | 85.57 |
| Progyny (PGNY) | United States | $1.886B | 41.51 |
| PACS (PACS) | United States | $1.823B | 0.00 |
| Premier (PINC) | United States | $1.725B | 13.09 |
| GoodRx Holdings (GDRX) | United States | $1.672B | 33.43 |
| Ardent Health (ARDT) | United States | $1.589B | 6.77 |
| Teladoc Health (TDOC) | United States | $1.412B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.277B | 438.00 |
| Establishment Labs Holdings (ESTA) | $1.202B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.080B | 8.22 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.878B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.759B | 7.10 |
| CareDx (CDNA) | United States | $0.663B | 10.36 |
| Nutex Health (NUTX) | United States | $0.632B | 9.57 |
| So-Young (SY) | China | $0.595B | 0.00 |
| SBC Medicals (SBC) | United States | $0.585B | 0.00 |
| Embecta (EMBC) | United States | $0.572B | 3.85 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| LifeMD (LFMD) | United States | $0.479B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| Omada Health (OMDA) | $0.453B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.402B | 0.00 |
| Enhabit (EHAB) | United States | $0.342B | 28.12 |
| Oncology Institute (TOI) | United States | $0.312B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.297B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.146B | 0.00 |
| DocGo (DCGO) | United States | $0.146B | 23.83 |
| Sera Prognostics (SERA) | United States | $0.110B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| KindlyMD (NAKA) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.047B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| ModivCare (MODV) | United States | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.043B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |